Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy

Επιστημονική δημοσίευση - Άρθρο Περιοδικού uoadl:3032129 11 Αναγνώσεις

Μονάδα:
Ερευνητικό υλικό ΕΚΠΑ
Τίτλος:
Role of autophagy in cholangiocarcinoma: An autophagy-based treatment
strategy
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Cholangiocarcinomas (CCAs) are diverse biliary epithelial tumours
involving the intrahepatic, perihilar and distal parts of the biliary
tree. The three entirely variable entities have distinct epidemiology,
molecular characteristics, prognosis and strategy for clinical
management. However, many cholangiocarcinoma tumor-cells appear to be
resistant to current chemotherapeutic agents. The role of autophagy and
the therapeutic value of autophagy-based therapy are largely unknown in
CCA. The multistep nature of autophagy offers a plethora of regulation
points, which are prone to be deregulated and cause different human
diseases, including cancer. However, it offers multiple targetable
points for designing novel therapeutic strategies. Tumor cells have
evolved to use autophagy as an adaptive mechanism for survival under
stressful conditions such as energy imbalance and hypoxic region of
tumors within the tumor microenvironment, but also to increase
invasiveness and resistance to chemotherapy. The purpose of this review
is to summarize the current knowledge regarding the interplay between
autophagy and cholangiocarcinogenesis, together with some preclinical
studies with agents that modulate autophagy in order to induce tumor
cell death. Altogether, a combinatorial strategy, which comprises the
current anti-cancer agents and autophagy modulators, would represent a
positive CCA patient approach.
Έτος δημοσίευσης:
2021
Συγγραφείς:
Koustas, Evangelos
Trifylli, Eleni-Myrto
Sarantis, Panagiotis
and Papavassiliou, Athanasios G.
Karamouzis, V, Michalis
Περιοδικό:
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY
Εκδότης:
BAISHIDENG PUBLISHING GROUP INC
Τόμος:
13
Αριθμός / τεύχος:
10
Σελίδες:
1229-1243
Λέξεις-κλειδιά:
Autophagy; Autophagy modulators; Chemotherapy; Cholangiocarcinoma
Επίσημο URL (Εκδότης):
DOI:
10.4251/wjgo.v13.i10.1229
Το ψηφιακό υλικό του τεκμηρίου δεν είναι διαθέσιμο.